Skip to content
Delayed ~15 min

CADL CANDEL THERAPEUTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 14 analyst firms say about CANDEL THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

8.75 USD+0.71 (+8.83%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+138.7%to the avg target 20.89 USD+12.14 USD
Buy 12 · Hold 0 · Sell 1

13 rated views · 14 analyst/firm records · 14 firms

Latest report22 Oct 2026avg report date 5 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8065
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8039

Recent analyst activity · last 90 days

Our tracked history has 8 reports on CADL from 6 analyst firms in the last 90 days (14 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 1 has its first observed target in the past year.

Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.

Latest observed target change: BofA Securities raised its target from $12.00 (set 14 Aug 2026) to $18.00 on 21 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesAlec StranahanBuy21 Sep 202618.00 USD
Brookline Capital MarketsKemp DolliverBuy17 May 202629.00 USD
Canaccord GenuityJohn NewmanBuy13 Mar 202625.00 USD
Cantor FitzgeraldImogen MansfieldBuy20 Apr 2026—
CitigroupYigal NochomovitzBuy13 Mar 2026Conflicting reports · excluded
Freedom Capital MarketsIlya ZubkovBuy1 Jul 202615.00 USD
H.C. WainwrightAndres Y. MaldonadoBuy2 Oct 202623.00 USD · 29 Jul 2026
JefferiesMaury RaycroftBuy22 Oct 202625.00 USD
Lifesci CapitalOliver MccammonBuy12 Mar 202616.00 USD
StephensSudan LoganathanBuy8 Dec 202515.00 USD
StifelStephen WilleyBuy13 Jul 202622.00 USD
UBSUnnamed analystBuy17 Aug 2026—
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamSell14 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.